Originally posted in Medgadget on JULY 24TH, 2015 RADIANT INSIGHTS, INC.
Global Markets Direct’s, ‘Sleep Apnea – Pipeline Review, H2 2014′, provides an overview of the Sleep Apnea’s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Sleep Apnea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.
It also reviews key players involved in the therapeutic development for Sleep Apnea and special features on late-stage and discontinued projects.
To Get More Details @http://www.radiantinsights.com/research/sleep-apnea-pipeline-review-h2-2014
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.Read More
Limited () has received FDA 510(k) approval from the U.S. Department of Health & Human Services for its sleep apnea devices, allowing it to start sales in July.
The approvals were received for its new SomnoDent® Fusion Classic and SomnoDent® Fusion Flex oral appliances that were introduced at conventions at the beginning of June.
These have exchangeable wings, which makes adjustments of the forward position of the SomnoDent® device easier for the practitioner and patient.
Both products offer improvements over existing sleep apnea devices and a greater level of patient comfort.
The company’s products are already distributed throughout 16 countries in Europe, which represents 40% of its global sales.
Outlook for European sales volume and revenue growth in FY14/15 is strong.
Originally posted in Proactiveinvestors.Read More